Found 12 matching trials
Diagnostic Accuracy of APAC, ASAP and GALAD Scores in Hepatocellular Carcinoma Among Cirrhotic Patients
N/AHepatocellular carcinoma (HCC) is the most common primary liver malignancy ...
Location
Sohag University Hospital
AFP- L3% and DCP as Tumor Markers in Patients With Hepatocellular Carcinoma (HCC) Treated With Transarterial Chemoembolisation (TACE)
N/AHepatocellular carcinoma (HCC) is one of the tumors with an increasing inci...
Location
University Medical Center Freiburg
National Liver Cancer Screening Trial
PHASE4The National Liver Cancer Screening Trial is an adaptive randomized phase I...
Location
University of Southern California
Surveillance Study for HCC by Combining Biomarkers With Imaging (ALDUS)
N/AThis study is intended to be a prospective observational study at multiple ...
Location
Graduate School of Medicine and Faculty of Medicine, The University of Tokyo
Use of Blood Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma (HCC)
N/AThe objective of this observational study is to evaluate the clinical utili...
Location
RCCS "Saverio de Bellis"
Diagnostic Value of AFP-L3 and PIVKA-II in HCC
N/AThe incidence of Hepatocellular carcinoma (HCC) is increasing worldwide. Ho...
Location
Hanoi Medical University
HCC Risk and Monitoring in Patients With Type 2 Diabetes
NALiver cancer is a significant malignancy in Taiwan. With the widespread imp...
Location
National Taiwan University Hospital
Combining Biomarkers (AFP, AFP-L3, and PIVKA-II) and Image Tools for Early Detection of Hepatocellular Carcinoma
NAIn this study, three biomarkers tests (AFP, AFP-L3 and PIVKA-II) and abdomi...
Location
Korea University Ansan Hospital
AFP - L3% and DCP as Screening Marker for a Hepatocellular Carcinoma in Patients With Cirrhosis of the Liver
N/AHepatocellular carcinoma (HCC) is one of the tumors with a rising incidence...
Location
University Medical Center Freiburg
International Study of High-Risk Patients for Hepatocellular Carcinoma Using Liquid Biopsy
N/AThis study has two purposes. One is to conduct a phase IV biomarker validat...
Location
King Faisal Specialist Hospital and Research Center in Jeddah